Related Experiment Video
Updated: May 21, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Recent advances in the management of difficult constipation
Brian E Lacy1, John Levenick, Michael Crowell
1Division of Gastroenterology & Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. Brian.E.Lacy@hitchcock.org
Chronic constipation affects many, reducing quality of life and increasing healthcare costs. This report reviews recent advances in managing difficult constipation, including new treatments and diagnostic tools.
Area of Science:
- Gastroenterology
- Internal Medicine
Background:
- Constipation is a common disorder with acute and chronic forms.
- Chronic constipation, lasting over 6 months, significantly impacts quality of life and healthcare economics.
- Difficult constipation refers to cases unresponsive to standard treatments.
Purpose of the Study:
- To review recent advancements in managing difficult constipation.
- To discuss novel diagnostic tests and emerging therapeutic options.
Main Methods:
- Literature review of recent studies on difficult constipation management.
- Analysis of new diagnostic procedures and pharmacological interventions.
Main Results:
- Emerging diagnostic tools offer improved identification of constipation causes.
- New medications show promise for refractory chronic constipation.
- Lifestyle changes and current treatments are often insufficient for difficult cases.
Conclusions:
- Advances in diagnostics and therapeutics are improving the management of difficult constipation.
- Further research is needed to fully elucidate the potential of new treatments.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...